Log In
Print
BCIQ
Print
Print this Print this
 

MLN1117 (formerly INK1117)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionInhibitor of Phosphoinositide 3-kinase (PI3K) alpha
Molecular Target Phosphoinositide 3-kinase (PI3K) alpha
Mechanism of ActionPhosphoinositide 3-kinase (PI3K) alpha inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid malignancies
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today